Thomas Bourgeron

Genetic markers in psychiatric genetics.

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.

[Genetics of autism: from genome scans to candidate genes].

Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.

Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders.

No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects.

Searching for ways out of the autism maze: genetic, epigenetic and environmental clues.

Fragile X syndrome and autism at the intersection of genetic and neural networks.

Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

Mapping autism risk loci using genetic linkage and chromosomal rearrangements.

[Genetics and business: in defence of free speech!].

[Alterations in synapsis formation and function in autism disorders].

Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.

Analysis of X chromosome inactivation in autism spectrum disorders.

An investigation of ribosomal protein L10 gene in autism spectrum disorders.

A synaptic trek to autism.

Reduced 3-O-methyl-dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele.

[Autism: more evidence of a genetic cause].

Functional impact of global rare copy number variation in autism spectrum disorders.

Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls.

Key role for gene dosage and synaptic homeostasis in autism spectrum disorders.

Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.

A genome-wide scan for common alleles affecting risk for autism.

Production of soluble, active acetyl serotonin methyl transferase in Leishmania tarentolae.

Against le packing: a consensus statement.

Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability.

Behavioral profiles of mouse models for autism spectrum disorders.

Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations.

Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland.

Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders.

A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder.

Adult male mice emit context-specific ultrasonic vocalizations that are modulated by prior isolation or group rearing environment.

Genetic variants of FOXP2 and KIAA0319/TTRAP/THEM2 locus are associated with altered brain activation in distinct language-related regions.

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.

SHANK1 Deletions in Males with Autism Spectrum Disorder.

Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder.

Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2.

High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters.

Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway.

Significant correlation between a set of genetic polymorphisms and a functional brain network revealed by feature selection and sparse Partial Least Squares.

Individual common variants exert weak effects on the risk for autism spectrum disorderspi.

Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.

Sequencing ASMT identifies rare mutations in Chinese Han patients with autism.

Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites.

Progress toward treatments for synaptic defects in autism.

The genetic landscapes of autism spectrum disorders.

The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations.

The emerging role of SHANK genes in neuropsychiatric disorders.

Heterozygous FA2H mutations in autism spectrum disorders.

Neurobiology of autism gene products: towards pathogenesis and drug targets.

Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders.

Screening, intervention and outcome in autism and other developmental disorders: the role of randomized controlled trials.

Heterogeneous pattern of selective pressure for PRRT2 in human populations, but no association with autism spectrum disorders.

Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.

Genetic and Environmental Influences on the Visual Word Form and Fusiform Face Areas.

Vitamin d in the general population of young adults with autism in the faroe islands.

Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.

Social communication in mice--are there optimal cage conditions?

Neuroanatomical Diversity of Corpus Callosum and Brain Volume in Autism: Meta-analysis, Analysis of the Autism Brain Imaging Data Exchange Project, and Simulation.

The genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture.

From the genetic architecture to synaptic plasticity in autism spectrum disorder.

11q24.2-25 micro-rearrangements in autism spectrum disorders: Relation to brain structures.

A de novo microdeletion of SEMA5A in a boy with autism spectrum disorder and intellectual disability.